MedPath
NMPA Approval

Ebastine Oral Solution

国药准字H20243051

January 16, 2024

Drug Information

依巴斯汀口服溶液

口服溶液剂

120ml:120mg

化学药品

January 16, 2024

Company Information

Applicant Company

长沙市浏阳经济技术开发区健康大道1号

Manufacturing Company

长沙市浏阳经济技术开发区健康大道1号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

依巴斯汀口服溶液 - NMPA 批准文号 | MedPath